Karin Weißer

2.9k total citations · 1 hit paper
38 papers, 1.8k citations indexed

About

Karin Weißer is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Nutrition and Dietetics. According to data from OpenAlex, Karin Weißer has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Health, Toxicology and Mutagenesis and 7 papers in Nutrition and Dietetics. Recurrent topics in Karin Weißer's work include Heavy Metal Exposure and Toxicity (8 papers), Aluminum toxicity and tolerance in plants and animals (7 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Karin Weißer is often cited by papers focused on Heavy Metal Exposure and Toxicity (8 papers), Aluminum toxicity and tolerance in plants and animals (7 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Karin Weißer collaborates with scholars based in Germany, Switzerland and Canada. Karin Weißer's co-authors include Andreas Greinacher, Thomas Thiele, Sabine Eichinger, Paul A. Kyrle, Theodore E. Warkentin, Brigitte Keller‐Stanislawski, E. Mutschler, J. Schloos, R. Hopf and Beate Krämer and has published in prestigious journals such as New England Journal of Medicine, Biochemical Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Karin Weißer

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

2021 1.4k citations Andreas Greinacher, Thomas Thiele et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Weißer Germany	13	969	612	605	299	289	38	1.8k
Jan van Hattum Netherlands	33	354 0.4×	167 0.3×	236 0.4×	21 0.1×	64 0.2×	69	2.6k
Nilesh Chande Canada	30	872 0.9×	126 0.2×	169 0.3×	35 0.1×	120 0.4×	95	3.2k
Preeti Jaggi United States	20	728 0.8×	638 1.0×	90 0.1×	44 0.1×	12 0.0×	75	1.8k
Loek P. Smits Netherlands	14	324 0.3×	1.2k 1.9×	42 0.1×	26 0.1×	427 1.5×	17	2.3k
Idit F. Schwartz Israel	20	148 0.2×	485 0.8×	77 0.1×	23 0.1×	8 0.0×	71	1.8k
Francesco Dima Italy	17	112 0.1×	156 0.3×	105 0.2×	14 0.0×	34 0.1×	62	1.1k
Jenneke Leentjens Netherlands	15	94 0.1×	467 0.8×	47 0.1×	13 0.0×	86 0.3×	33	1.9k
Ritchard G. Cable United States	32	65 0.1×	388 0.6×	1.2k 2.0×	32 0.1×	35 0.1×	85	2.7k
Mahesh Gajendran United States	19	422 0.4×	562 0.9×	43 0.1×	39 0.1×	9 0.0×	65	1.9k

Countries citing papers authored by Karin Weißer

Since Specialization

Citations

This map shows the geographic impact of Karin Weißer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Weißer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Weißer more than expected).

Fields of papers citing papers by Karin Weißer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Weißer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Weißer. The network helps show where Karin Weißer may publish in the future.

Co-authorship network of co-authors of Karin Weißer

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Weißer. A scholar is included among the top collaborators of Karin Weißer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Weißer. Karin Weißer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hartung, Niklas, Gaby Wangorsch, Wilhelm Huisinga, & Karin Weißer. (2025). Extension and validation of a physiologically based toxicokinetic model for risk assessment of aluminium exposure in humans. Archives of Toxicology. 99(6). 2379–2395. 4 indexed citations

Hartung, Niklas, Steven A. Abrams, Wilhelm Huisinga, & Karin Weißer. (2024). Calcium kinetic rates in Caucasian males and females from birth to adulthood. Bone. 189. 117254–117254. 2 indexed citations

Weißer, Karin, et al.. (2023). Anaphylactic reactions after COVID-19 vaccination in Germany. PubMed. 7(1). 90–100. 3 indexed citations

Thiele, Thomas, Karin Weißer, Linda Schönborn, et al.. (2021). Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany. The Lancet Regional Health - Europe. 12. 100270–100270. 32 indexed citations

Robertson, James S., et al.. (2021). International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety. Vaccine. 40(1). 21–27. 4 indexed citations

Hartung, Niklas, et al.. (2021). Physiology-based toxicokinetic modelling of aluminium in rat and man. Archives of Toxicology. 95(9). 2977–3000. 16 indexed citations

Greinacher, Andreas, Thomas Thiele, Theodore E. Warkentin, et al.. (2021). Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. New England Journal of Medicine. 384(22). 2092–2101. 1431 indexed citations breakdown →

Weißer, Karin, Thomas Göen, Jennifer D. Oduro, et al.. (2019). Aluminium in plasma and tissues after intramuscular injection of adjuvanted human vaccines in rats. Archives of Toxicology. 93(10). 2787–2796. 11 indexed citations

Weißer, Karin, et al.. (2017). Towards toxicokinetic modelling of aluminium exposure from adjuvants in medicinal products. Regulatory Toxicology and Pharmacology. 88. 310–321. 19 indexed citations

10.

Isbrucker, Richard, Hans‐Peter Ottiger, Robert J. Tierney, et al.. (2014). Results of an international transferability study of the BINACLE (binding and cleavage) assay for in vitro detection of tetanus toxicity. Biologicals. 42(4). 199–204. 2 indexed citations

11.

Hanschmann, Kay-Martin, et al.. (2013). Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: Applicability as alternative method for the safety testing of tetanus toxoids during vaccine production. Vaccine. 31(52). 6247–6253. 14 indexed citations

12.

Weißer, Karin, et al.. (2009). Sicherheit von Impfstoffen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 52(11). 1053–1064. 12 indexed citations

13.

Krämer, Beate, et al.. (2009). In vitro determination of tetanus toxicity by an endopeptidase assay linked to a ganglioside-binding step. Toxicology in Vitro. 24(3). 988–994. 12 indexed citations

14.

Weißer, Karin, et al.. (2008). Residual enzymatic activity of the tetanus toxin light chain present in tetanus toxoid batches used for vaccine production. Vaccine. 26(31). 3835–3841. 17 indexed citations

15.

Weißer, Karin, Karin Bauer, Peter Volkers, & Brigitte Keller‐Stanislawski. (2004). Thiomersal und Impfungen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 47(12). 1165–1174. 6 indexed citations

16.

Mey, Christian de, R. Butzer, Patrick Jahn, et al.. (1995). Dose-Effect and Kinetic-Dynamic Relationships of the (β-Adrenoceptor Blocking Properties of Various Doses of Talinolol in Healthy Humans. Journal of Cardiovascular Pharmacology. 26(6). 879–888. 10 indexed citations

17.

Witte, Klaus K., et al.. (1993). Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clinical Pharmacology & Therapeutics. 54(2). 177–186. 74 indexed citations

18.

Weißer, Karin, J. Schloos, Stephan M. Jakob, et al.. (1992). The influence of hydrochlorothiazide on the pharmacokinetics of enalapril in elderly patients. European Journal of Clinical Pharmacology. 43(2). 173–177. 6 indexed citations

19.

Weißer, Karin & J. Schloos. (1991). The role of enzyme and substrate concentration in the evaluation of serum angiotensin converting enzyme (ACE) inhibition by enalaprilat in vitro. Biochemical Pharmacology. 42(9). 1729–1737. 15 indexed citations

20.

Weißer, Karin, et al.. (1991). Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects. European Journal of Clinical Pharmacology. 40(1). 95–99. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact